A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Clinical trial NCT07097259 · COMPLETED
Trial details
- NCT number
- NCT07097259
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-21
- Primary completion
- 2025-12-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.